Showing results (1-10 of 649) with videos related to
Sort By:
Pageof 65
Nature Cancer|December 12, 2022
Two isoleucyl tRNAs that decode synonymous codons divergently regulate breast cancer metastatic growth by controlling translation of proliferation-regulating genesLisa B Earnest-Noble, Dennis Hsu, Siyu Chen, et al.Nature Cancer|October 19, 2020
What next for postdocs?Nature Cancer|December 22, 2022
Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypesDo Young Hyeon, Dowoon Nam, Youngmin Han, et al.Nature Cancer|December 23, 2022
YAP/TAZ as master regulators in cancer: modulation, function and therapeutic approachesStefano Piccolo, Tito Panciera, Paolo Contessotto, et al.Nature Cancer|June 24, 2021
A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damageXueqing Zou, Gene Ching Chiek Koh, Arjun Scott Nanda, et al.Nature Cancer|December 29, 2022
An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemiaAudrey Lasry, Bettina Nadorp, Maarten Fornerod, et al.Nature Cancer|June 28, 2022
Charting roadmaps towards novel and safe synergistic immunotherapy combinationsMiguel F Sanmamed, Pedro Berraondo, Maria E Rodriguez-Ruiz, et al.Nature Cancer|November 28, 2022
Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockadeLiam F Spurr, Carlos A Martinez, Wenjun Kang, et al.Nature Cancer|April 9, 2025
Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysisSophie Cousin, Jean-Philippe Guégan, Lola Jade Palmieri, et al.Nature Cancer|April 3, 2025
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA studyGuillaume Cartron, Roch Houot, Yassine Al Tabaa, et al.Pageof 65